SLC7A11 and neoplasm: The ability of SLC7A11 to modulate cellular redox status not only influences cell survival but also impacts the efficacy of various cancer therapies, as inhibiting SLC7A11 can sensitize tumor cells to ferroptosis and enhance the effects of chemotherapy (Ouyang et al., 2022).